Resolution: standard / high
Figure 3.
Current use of symptomatic treatments for fatigue based on the use of IMA. IMA = NARCOMS respondents treated with IMA;No IMA = NARCOMS respondents not treated with IMAs. 4-AP, 4-aminopyridine; IMA, immunomodulatory agents.
Hadjimichael et al. Health and Quality of Life Outcomes 2008 6:100 doi:10.1186/1477-7525-6-100
Download authors' original image